CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the global launch of its Biodata Network, a portfolio of data-driven partnering solutions, including Biodata Licenses and Insight Reports, for biopharma and research institutions
By Centogene NV
Published - Nov 03, 2022, 06:06 AM ET
Last Updated - Jul 24, 2024, 01:55 AM EDT